Drug ID: 2d00000065
Drug Name: Bulaquine
Generic Names: Aablaquin
Category: Anti- Malarials
Legal Status: Non Opioid Prescription only drug
Indication for Mother: Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Recommended Dose: The recommended dose is 25mg once daily for 5 days.
Recommended In: This medication is an antimalarial agent, prescribed for malarial fever with chloroquine.
Directions For Use: It comes as a capsule to take by mouth, with or without food.
Storage: Store in an airtight container, and in a cool place.
Dosage Forms: Capsule
Side Effects: No significant side effects. The drug has a good safety profile.
In Case of Overdose: Give supportive measures and symptomatic treatment.
Avoid If: Contraindicated in patients with rheumatoid arthritis, systemic lupus erythematosus and co-administration of drugs known to cause haemolysis.
Caution should be exercised in patients with history of G6PDH deficiency, during pregnancy and breastfeeding.
Drug Interaction: No significant adverse drug reaction is observed yet.